Department of Nephrology, Jiangmen Central Hospital, Jiangmen, China.
Department of Medical Statistics, Clinical Trials Unit, The First Affiliated Hospital, Sun Yat-sen Univeristy, Guangzhou, China.
Nutr Metab Cardiovasc Dis. 2023 May;33(5):1049-1056. doi: 10.1016/j.numecd.2023.02.009. Epub 2023 Feb 16.
Remnant cholesterol (RC) adversely contributes to cardiovascular disease (CVD) and overall survival in various diseases. However, its role in CVD outcomes and all-cause mortality in patients undergoing peritoneal dialysis (PD) is limited. Therefore, we aimed to investigate the association between RC and all-cause and CVD mortality in patients undergoing PD.
Based on lipid profiles recorded using standard laboratory procedures, fasting RC levels were calculated in 2710 incident patients undergoing PD who were enrolled between January 2006 and December 2017 and followed up until December 2018. Patients were divided into four groups according to the quartile distribution of baseline RC levels (Q1: <0.40 mmol/L, Q2: 0.40 to <0.64 mmol/L, Q3: 0.64 to <1.03 mmol/L, and Q4: ≥1.03 mmol/L). Associations between RC and CVD and all-cause mortality were evaluated using multivariable Cox models. During the median follow-up period of 35.4 months (interquartile range, 20.9-57.2 months), 820 deaths were recorded, of which 438 were CVD-related. Smoothing plots showed non-linear relationships between RC and adverse outcomes. The risks of all-cause and CVD mortality increased progressively through the quartiles (log-rank, p < 0.001). Using adjusted proportional hazard models, a comparison of the highest (Q4) to lowest (Q1) quartiles revealed significant increases in the hazard ratio (HR) for all-cause mortality (HR 1.95 [95% confidence interval (CI), 1.51-2.51]) and CVD mortality risk (HR 2.60 [95% CI, 1.80-3.75]).
An increased RC level was independently associated with all-cause and CVD mortality in patients undergoing PD, suggesting that RC was important clinically and required further research.
残余胆固醇(RC)对各种疾病的心血管疾病(CVD)和整体生存均有不良影响。然而,在接受腹膜透析(PD)的患者中,其对 CVD 结局和全因死亡率的作用有限。因此,我们旨在研究 PD 患者中 RC 与全因和 CVD 死亡率之间的关系。
基于使用标准实验室程序记录的血脂谱,在 2006 年 1 月至 2017 年 12 月期间入组并随访至 2018 年 12 月的 2710 例 PD 新发病例患者中,计算空腹 RC 水平。根据 RC 基线水平的四分位分布(Q1:<0.40mmol/L,Q2:0.40-<0.64mmol/L,Q3:0.64-<1.03mmol/L,Q4:≥1.03mmol/L)将患者分为四组。使用多变量 Cox 模型评估 RC 与 CVD 和全因死亡率之间的关系。在中位随访期 35.4 个月(四分位间距 20.9-57.2 个月)期间,记录了 820 例死亡事件,其中 438 例与 CVD 相关。平滑图显示 RC 与不良结局之间存在非线性关系。全因和 CVD 死亡率随着四分位组的增加而逐渐增加(对数秩检验,p<0.001)。使用调整后的比例风险模型,与最低四分位组(Q1)相比,最高四分位组(Q4)的全因死亡率(风险比 1.95[95%置信区间(CI),1.51-2.51])和 CVD 死亡率风险(风险比 2.60[95% CI,1.80-3.75])显著增加。
RC 水平升高与 PD 患者的全因和 CVD 死亡率独立相关,表明 RC 在临床上很重要,需要进一步研究。